Top Markets
#1 Seeker Seeker +18.80%
#2 EXOD EXOD +9.04%
#3 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.47%
#4 Arowana Arowana +5.88%
#5 MetaDAO MetaDAO +4.67%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +4.02%
#7 Mina Protocol Mina Protocol +3.88%
#8 Pons Pons +3.00%
#9 Solstice Solstice +2.88%
#10 Official Trump Official Trump +2.75%
Coin of the day
Seeker Seeker
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Clasificación en acciones #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Precio por acción
$64.97
Última sincronización: 2024-05-20
Capitalización bursátil
$1.97B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Alpine Immune Sciences, Inc. (ALPN)

Categoría

Healthcare
Número de acciones en circulación de Alpine Immune Sciences, Inc. (ALPN)
Número de acciones en circulación al March 2024: 64.03M
Según los últimos informes financieros y el precio de las acciones de Alpine Immune Sciences, Inc., el número actual de acciones en circulación es 64.03M. Al final de December 2022, la empresa tenía 33.44M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Alpine Immune Sciences, Inc. (ALPN) desde 2012 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
2026 (TTM) 64.03M 28.07%
2023 50.00M 49.54%
2022 33.44M 31.24%
2021 25.48M 22.33%
2020 20.83M 13.44%
2019 18.36M 32.56%
2018 13.85M 113.67%
2017 6.48M 67.36%
2016 3.87M 65.32%
2015 2.34M 2.70%
2014 2.28M 0.00%
2013 2.28M 0.00%
2012 2.28M 0.00%
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 296.51%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -2.89%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 647.91%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 518.43%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH